Actinium Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: New York NY United States (2000)

Organization Overview

First Clinical Trial
2005
NCT00672165
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Actinium Pharmaceuticals | Actinium Pharmaceuticals Inc.